US5250022A
(en)
*
|
1990-09-25 |
1993-10-05 |
Rutgers, The State University Of New Jersey |
Iontotherapeutic devices, reservoir electrode devices therefore, process and unit dose
|
US5080646A
(en)
*
|
1988-10-03 |
1992-01-14 |
Alza Corporation |
Membrane for electrotransport transdermal drug delivery
|
US5549924A
(en)
*
|
1987-07-17 |
1996-08-27 |
Robin Renee Thill Shlenker |
Method of forming a membrane, especially a latex or polymer membrane, including a deactivating barrier and indicating layer
|
US5679399A
(en)
*
|
1987-07-17 |
1997-10-21 |
Bio Barrier, Inc. |
Method of forming a membrane, especially a latex or polymer membrane, including multiple discrete layers
|
US4927408A
(en)
*
|
1988-10-03 |
1990-05-22 |
Alza Corporation |
Electrotransport transdermal system
|
US5496266A
(en)
*
|
1990-04-30 |
1996-03-05 |
Alza Corporation |
Device and method of iontophoretic drug delivery
|
US5147296A
(en)
*
|
1988-10-03 |
1992-09-15 |
Alza Corporation |
Membrane for electrotransport transdermal drug delivery
|
US5169382A
(en)
*
|
1988-10-03 |
1992-12-08 |
Alza Corporation |
Membrane for electrotransport transdermal drug delivery
|
US5240995A
(en)
*
|
1989-02-09 |
1993-08-31 |
Alza Corporation |
Electrotransport adhesive
|
US5234992A
(en)
*
|
1989-02-09 |
1993-08-10 |
Alza Corporation |
Electrotransport adhesive
|
CA2067820A1
(en)
*
|
1989-10-23 |
1991-04-24 |
Srinivasan Venkateshwaran |
Iontophoresis device and method using a rate-controlling membrane
|
JP2816886B2
(ja)
*
|
1990-03-05 |
1998-10-27 |
興和株式会社 |
生体通電装置
|
GR1000433B
(el)
*
|
1990-04-24 |
1992-07-30 |
Alza Corp |
Συσκευη και μεθοδος ιοντοφορητικης απελευθερωσης φαρμακου.
|
US5147297A
(en)
*
|
1990-05-07 |
1992-09-15 |
Alza Corporation |
Iontophoretic delivery device
|
US5362308A
(en)
*
|
1990-09-25 |
1994-11-08 |
Rutgers, The State University Of New Jersey |
Disposable dosage unit for iontophoresis-facilitated transdermal delivery, related devices and processes
|
US5677360A
(en)
*
|
1991-02-13 |
1997-10-14 |
Mitsubishi Rayon Co., Ltd. |
Hydrophilic polymer alloy, fiber and porous membrane comprising this polymer alloy, and methods for preparing them
|
US5405317A
(en)
*
|
1991-05-03 |
1995-04-11 |
Alza Corporation |
Iontophoretic delivery device
|
US5402777A
(en)
*
|
1991-06-28 |
1995-04-04 |
Alza Corporation |
Methods and devices for facilitated non-invasive oxygen monitoring
|
US5356632A
(en)
*
|
1991-09-12 |
1994-10-18 |
S.I. Scientific Innovations Ltd. |
Transdermal drug delivery device
|
SE9102778D0
(sv)
*
|
1991-09-25 |
1991-09-25 |
Siemens Elema Ab |
Implanterbar medicinsk anordning
|
US5421816A
(en)
*
|
1992-10-14 |
1995-06-06 |
Endodermic Medical Technologies Company |
Ultrasonic transdermal drug delivery system
|
CA2126487C
(en)
*
|
1993-06-23 |
2001-05-29 |
Keiichiro Okabe |
Iontophoresis device
|
US5387189A
(en)
*
|
1993-12-02 |
1995-02-07 |
Alza Corporation |
Electrotransport delivery device and method of making same
|
US5508262A
(en)
*
|
1993-12-15 |
1996-04-16 |
University Of South Florida |
Interleukin-1 receptor antagonist decreases severity of acute pancreatitis
|
WO1995027530A1
(en)
*
|
1994-04-08 |
1995-10-19 |
Alza Corporation |
Electrotransport system with ion exchange competitive ion capture
|
FR2719485B1
(fr)
*
|
1994-05-06 |
1996-07-12 |
Lhd Lab Hygiene Dietetique |
Procédé et dispositif de mesure de la quantité d'un principe actif contenu dans un réservoir.
|
JP3523334B2
(ja)
*
|
1994-07-02 |
2004-04-26 |
久光製薬株式会社 |
イオントフォレ−シス用プラスター構造体
|
US5861439A
(en)
*
|
1994-11-14 |
1999-01-19 |
Alza Corporation |
Method for enhanced electrotransport agent delivery
|
FR2726769B1
(fr)
*
|
1994-11-16 |
1997-01-31 |
Lhd Lab Hygiene Dietetique |
Dispositif ionophoretique d'administration transdermique de medicaments et ensemble jetable formant partie d'un tel dispositif
|
US5855867A
(en)
*
|
1995-03-29 |
1999-01-05 |
The Curators Of The University Of Missouri |
Hydroxymethyl phosphine compounds for use as diagnostic and therapeutic pharmaceuticals and method of making same
|
IL113459A
(en)
*
|
1995-04-23 |
2000-07-16 |
Electromagnetic Bracing System |
Electrophoretic cuff apparatus
|
EP1131131A1
(en)
*
|
1995-04-23 |
2001-09-12 |
Electromagnetic Bracing Systems, Inc. |
Transdermal active drug delivery system and method
|
US5853383A
(en)
*
|
1995-05-03 |
1998-12-29 |
Alza Corporation |
Preparation for formulations for electrotransport drug delivery
|
US6425892B2
(en)
|
1995-06-05 |
2002-07-30 |
Alza Corporation |
Device for transdermal electrotransport delivery of fentanyl and sufentanil
|
US6216033B1
(en)
|
1996-05-22 |
2001-04-10 |
Alza Corporation |
Device for transdermal electrotransport delivery of fentanyl and sufentanil
|
AT409720B
(de)
*
|
1995-06-05 |
2002-10-25 |
Alza Corp |
Vorrichtung zur selbstverabreichung von analgetika
|
US6881208B1
(en)
*
|
1995-06-05 |
2005-04-19 |
Joseph B. Phipps |
Method and device for transdermal electrotransport delivery of fentanyl and sufentanil
|
ZA964320B
(en)
*
|
1995-06-05 |
1997-01-13 |
Alza Corp |
Device for transdermal electrotransport delivery of fentanyl and sufentanil
|
US5747453A
(en)
|
1995-06-06 |
1998-05-05 |
Alza Corporation |
Method for increasing the electrotransport flux of polypeptides
|
US7572252B1
(en)
|
1995-06-07 |
2009-08-11 |
Alza Corporation |
Electrotransport agent delivery method and apparatus
|
US5983130A
(en)
|
1995-06-07 |
1999-11-09 |
Alza Corporation |
Electrotransport agent delivery method and apparatus
|
US5767084A
(en)
*
|
1995-10-06 |
1998-06-16 |
The Curators Of The University Of Missouri |
Method of treatment for cystic fibrosis and peptides for same
|
WO1997017091A1
(en)
|
1995-11-08 |
1997-05-15 |
University Of South Florida |
Guinea pig model for leiomyomas and atherosclerosis
|
EP0942716B1
(en)
|
1996-01-30 |
2005-05-11 |
Novagent Oy |
Composition for transdermal delivery of drugs
|
US6333189B1
(en)
|
1996-06-06 |
2001-12-25 |
Alza Corporation |
Method of making an electrotransport device
|
US6718201B1
(en)
*
|
1996-06-07 |
2004-04-06 |
Alza Corporation |
Electrotransport agent delivery method and apparatus
|
AR008242A1
(es)
|
1996-06-18 |
1999-12-29 |
Alza Corp |
Dispositivo para atravesar el estrato corneo de una superficie corporal
|
EP0920345A4
(en)
*
|
1996-06-19 |
2006-05-10 |
Vyteris Inc |
IONTOPHORETIC ADMINISTRATION OF CELL ADHESION INHIBITORS
|
US5908400A
(en)
*
|
1996-06-20 |
1999-06-01 |
Hisamitsu Pharmaceutical Co., Inc. |
Device structure for iontophoresis
|
US5941843A
(en)
*
|
1996-07-12 |
1999-08-24 |
Empi, Inc. |
Iontophoresis electrode
|
US5857993A
(en)
*
|
1996-07-12 |
1999-01-12 |
Empi, Inc. |
Process of making an iontophoresis electrode
|
US5871461A
(en)
*
|
1996-07-12 |
1999-02-16 |
Empi, Inc. |
Method of making an iontophoresis electrode
|
US6350259B1
(en)
*
|
1996-09-30 |
2002-02-26 |
Vyteris, Inc. |
Selected drug delivery profiles using competing ions
|
US5906976A
(en)
*
|
1996-10-22 |
1999-05-25 |
Ramot-University Authority For Applied Research And Industrial Development, Ltd. |
Method and composition for treating neuronal degeneration
|
FR2755372B1
(fr)
*
|
1996-11-07 |
1998-12-24 |
Elf Aquitaine |
Dispositif d'ionophorese comportant au moins un ensemble electrode a membrane, pour l'administration transcutanee de principes actifs a un sujet
|
US6246904B1
(en)
|
1996-12-17 |
2001-06-12 |
Alza Corporation |
Electrotransport drug delivery reservoirs containing inert fillers
|
US6650934B2
(en)
|
1996-12-17 |
2003-11-18 |
Alza Corp |
Polymeric foam reservoirs for an electrotransport delivery device
|
US6119036A
(en)
|
1997-03-26 |
2000-09-12 |
The Board Of Regents Of The University Of Oklahoma |
Iontophoretic transdermal delivery device
|
US5976547A
(en)
*
|
1997-04-22 |
1999-11-02 |
Niblick Pharmaceuticals, Inc. |
Analgesic and antiphlogistic compositions and therapeutic wrap for topical delivery
|
US6004577A
(en)
*
|
1997-08-12 |
1999-12-21 |
Murdock; Thomas O. |
Enhanced electrotransport of therapeutic agents having polybasic anionic counter ions
|
US6775569B2
(en)
|
1997-11-05 |
2004-08-10 |
Hisamitsu Pharmaceutical Co., Inc. |
Electroporation device for in vivo delivery of therapeutic agents
|
CA2309818C
(en)
*
|
1997-11-12 |
2009-05-05 |
Alza Corporation |
Buffered drug formulations for transdermal electrotransport delivery
|
JP3980140B2
(ja)
*
|
1997-12-04 |
2007-09-26 |
村越 寧根 |
治療器具
|
US6918901B1
(en)
|
1997-12-10 |
2005-07-19 |
Felix Theeuwes |
Device and method for enhancing transdermal agent flux
|
EP1911488A3
(en)
|
1997-12-11 |
2008-12-03 |
Alza Corporation |
Device for enhancing transdermal agent flux
|
KR100557261B1
(ko)
|
1997-12-11 |
2006-03-07 |
알자 코포레이션 |
경피성 작용제 유동률을 증진시키기 위한 장치
|
CN1170603C
(zh)
*
|
1997-12-11 |
2004-10-13 |
阿尔扎有限公司 |
增强透皮物剂流量的装置
|
JP4061022B2
(ja)
*
|
1997-12-11 |
2008-03-12 |
アルザ・コーポレーション |
経皮輸送剤の流量促進装置
|
US6163720A
(en)
*
|
1997-12-18 |
2000-12-19 |
Alza Corporation |
Layered rate controlling membranes for use in an electrotransport device
|
US6374136B1
(en)
*
|
1997-12-22 |
2002-04-16 |
Alza Corporation |
Anhydrous drug reservoir for electrolytic transdermal delivery device
|
JP4154017B2
(ja)
*
|
1997-12-30 |
2008-09-24 |
久光製薬株式会社 |
イオントフォレーシス装置および薬物ユニット
|
US6489306B2
(en)
|
1998-02-23 |
2002-12-03 |
University Of South Florida |
Method of intranasal gene transfer for protection against respiratory infection
|
US6059736A
(en)
*
|
1998-02-24 |
2000-05-09 |
Tapper; Robert |
Sensor controlled analysis and therapeutic delivery system
|
US6028102A
(en)
*
|
1998-02-24 |
2000-02-22 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Anticonvulsant drugs and pharmaceutical compositions thereof
|
US6338834B1
(en)
|
1998-04-30 |
2002-01-15 |
The Curators Of The University Of Missouri |
Melanotropin analogs for potential radiopharmaceuticals for diagnosis and treatment of melanoma
|
US6344443B1
(en)
|
1998-07-08 |
2002-02-05 |
University Of South Florida |
Peptide antagonists of tumor necrosis factor alpha
|
US7605149B1
(en)
|
1998-07-13 |
2009-10-20 |
University Of South Florida |
Modulation of the phospholipase A2 pathway as a therapeutic
|
US7002003B1
(en)
|
1998-07-30 |
2006-02-21 |
University Of South Florida |
Method for the inhibition of function of STAT transcription factors
|
US6780397B2
(en)
|
1998-09-01 |
2004-08-24 |
Curators Of The University Of Missouri |
Biomolecule conjugation strategy using novel water-soluble phosphine-based chelating agents
|
US20050171021A1
(en)
*
|
1998-11-12 |
2005-08-04 |
Cormier Michel J. |
Buffered drug formulations for transdermal
|
US20070196490A1
(en)
*
|
1999-01-22 |
2007-08-23 |
Powderject Research Limited |
Method of enhancing needleless transdermal powered drug delivery
|
US6638974B1
(en)
|
1999-04-09 |
2003-10-28 |
University Of South Florida |
Ascorbyl esters for the treatment of cancer
|
US6787318B1
(en)
*
|
1999-06-01 |
2004-09-07 |
Roskamp Research Institute, Llc |
Assay for evaluating the therapeutic effectiveness of agents in reducing Alzheimer's disease pathology
|
CA2377373C
(en)
*
|
1999-06-14 |
2011-05-10 |
Henry Ford Health System |
Nitric oxide donors for inducing neurogenesis
|
US7135498B1
(en)
|
1999-06-14 |
2006-11-14 |
Henry Ford Health System |
Nitric oxide donors for inducing neurogenesis
|
US7655423B2
(en)
*
|
1999-06-14 |
2010-02-02 |
Henry Ford Health System |
Nitric oxide donors for inducing neurogenesis
|
US6394994B1
(en)
*
|
1999-08-27 |
2002-05-28 |
Vyteris, Inc. |
Method for testing the ability of an iontophoretic reservoir-electrode to deliver a medicament
|
US6998232B1
(en)
|
1999-09-27 |
2006-02-14 |
Quark Biotech, Inc. |
Methods of diagnosing bladder cancer
|
WO2001041756A2
(en)
|
1999-12-02 |
2001-06-14 |
University Of South Florida |
Method and composition for treatment of ischemic neuronal reperfusion injury
|
ES2253278T3
(es)
|
1999-12-10 |
2006-06-01 |
Alza Corporation |
Dispositivo y procedimiento para mejorar la perforacion cutanea con microprotuberancias.
|
WO2002003921A2
(en)
*
|
2000-07-11 |
2002-01-17 |
University Of South Florida |
Bax fragment induced tumor cell death
|
FR2812218B1
(fr)
*
|
2000-07-28 |
2003-01-10 |
Eastman Kodak Co |
Procede pour ameliorer le fonctionnement d'une membrane d'un dispositif de nanofiltration
|
US6803060B2
(en)
|
2000-09-07 |
2004-10-12 |
Joe Reyes |
Composition to boost libido
|
US20060194242A1
(en)
*
|
2000-10-27 |
2006-08-31 |
Hadden John W |
Immunotherapy for immune suppressed patients
|
US20070154399A1
(en)
*
|
2000-10-27 |
2007-07-05 |
Hadden John W |
Immunotherapy for immune suppressed patients
|
US20070025958A1
(en)
|
2000-10-27 |
2007-02-01 |
Hadden John W |
Vaccine immunotherapy
|
US6553255B1
(en)
|
2000-10-27 |
2003-04-22 |
Aciont Inc. |
Use of background electrolytes to minimize flux variability during iontophoresis
|
EP1337149A4
(en)
*
|
2000-10-27 |
2005-10-12 |
Irx Therapeutics Inc |
VACCINE IMMUNOTHERAPY FOR IMMUNE-PATIENT PATIENTS
|
US20070031372A1
(en)
*
|
2004-08-05 |
2007-02-08 |
Hadden John W |
Vaccine immunotherapy for immune suppressed patients
|
US7182942B2
(en)
*
|
2000-10-27 |
2007-02-27 |
Irx Therapeutics, Inc. |
Vaccine immunotherapy for immune suppressed patients
|
KR100856693B1
(ko)
*
|
2001-04-04 |
2008-09-04 |
알자 코포레이션 |
항미생물제 양립가능성 저장소 조성물을 포함하는 경피전기수송 전달 장치
|
US6770622B2
(en)
|
2001-06-08 |
2004-08-03 |
Gary A. Jarvis |
N-terminally truncated galectin-3 for use in treating cancer
|
DE10141650C1
(de)
*
|
2001-08-24 |
2002-11-28 |
Lohmann Therapie Syst Lts |
Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
|
US7731945B2
(en)
*
|
2001-10-26 |
2010-06-08 |
Immuno-Rx, Inc. |
Immunotherapy for reversing immune suppression
|
US7349733B2
(en)
|
2001-11-02 |
2008-03-25 |
Ceramatel, Inc. |
Iontophoretic drug delivery systems
|
US6775570B2
(en)
|
2002-02-04 |
2004-08-10 |
Ceramatec, Inc. |
Iontophoretic treatment device
|
US7047069B2
(en)
|
2002-02-04 |
2006-05-16 |
Ceramatec, Inc. |
Iontophoretic fluid delivery device
|
DE10205373B4
(de)
*
|
2002-02-09 |
2007-07-19 |
Aloys Wobben |
Brandschutz
|
EP1556061B1
(en)
*
|
2002-10-04 |
2007-04-18 |
Photokinetix Inc |
Photokinetic delivery of biologically active substances using pulsed incoherent light
|
WO2004037204A2
(en)
*
|
2002-10-25 |
2004-05-06 |
University Of South Florida |
Methods and compounds for disruption of cd40r/cd40l signaling in the treatment of alzheimer's disease
|
US6872292B2
(en)
*
|
2003-01-28 |
2005-03-29 |
Microlin, L.C. |
Voltage modulation of advanced electrochemical delivery system
|
US7220778B2
(en)
*
|
2003-04-15 |
2007-05-22 |
The General Hospital Corporation |
Methods and devices for epithelial protection during photodynamic therapy
|
AR045206A1
(es)
*
|
2003-08-04 |
2005-10-19 |
Alza Corp |
: componente de microproyeccion para insercion dentro de una superficie biologica.
|
EP1662879A4
(en)
*
|
2003-08-29 |
2009-03-11 |
Univ New York |
INDIRECT ADMINISTRATION OF GROWTH FACTORS IN THE CENTRAL NERVOUS SYSTEM
|
ES2389805T3
(es)
*
|
2003-09-12 |
2012-10-31 |
University Of Colorado |
Glutamina para su uso en el tratamiento de una lesión
|
BRPI0415761A
(pt)
*
|
2003-10-24 |
2006-12-19 |
Alza Corp |
aparelho e processo para reforçar a distribuição transdérmica de medicamento
|
CN1897898A
(zh)
*
|
2003-10-24 |
2007-01-17 |
阿尔扎公司 |
用于增强透皮药物传递的预处理方法和系统
|
US20050106227A1
(en)
*
|
2003-10-28 |
2005-05-19 |
Samuel Zalipsky |
Delivery of polymer conjugates of therapeutic peptides and proteins via coated microprojections
|
EP1682217A4
(en)
*
|
2003-11-13 |
2008-04-30 |
Alza Corp |
SYSTEM UDN PROCEDURE FOR THE TRANSDERMAL LEVY
|
US20050129655A1
(en)
*
|
2003-11-19 |
2005-06-16 |
David Rauser |
Methods for preparing polymeric buffer formulations for electrotransport applications
|
WO2005059100A2
(en)
*
|
2003-12-12 |
2005-06-30 |
New York University |
Methods and compositions relating to cystatin c
|
WO2005062718A2
(en)
*
|
2003-12-30 |
2005-07-14 |
Syndromex Ltd. |
Methods of administering 3,3,14,14 tetramethyl hexadecane 1,16 dioic acid
|
EP1758998B1
(en)
|
2004-01-30 |
2010-12-15 |
Quark Pharmaceuticals, Inc. |
Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases
|
US20050220439A1
(en)
*
|
2004-03-19 |
2005-10-06 |
Carton Owen A |
Interactive multimedia system and method
|
JP2007532645A
(ja)
*
|
2004-04-13 |
2007-11-15 |
アルザ コーポレイション |
フェンタニルに基づく薬剤の経皮送達システム用の器具および方法
|
JP5007427B2
(ja)
*
|
2004-05-13 |
2012-08-22 |
アルザ コーポレイション |
副甲状腺ホルモン剤の経皮送達のための装置および方法
|
EP1747672A4
(en)
*
|
2004-05-19 |
2010-02-17 |
Alza Corp |
METHOD AND FORMULATION OF TRANSDERMAL DELIVERY OF IMMUNOLOGICALLY ACTIVE AGENTS
|
US20060030811A1
(en)
*
|
2004-08-03 |
2006-02-09 |
Wong Patrick S |
Method and device for enhancing transdermal agent flux
|
TW200618830A
(en)
*
|
2004-08-10 |
2006-06-16 |
Alza Corp |
Micorprojection apparatus and system with low infection potential
|
AU2005277508B2
(en)
|
2004-08-16 |
2011-04-14 |
Quark Pharmaceuticals, Inc |
Therapeutic uses of inhibitors of RTP801
|
AR050608A1
(es)
*
|
2004-08-19 |
2006-11-08 |
Alza Corp |
Aparato y metodo para administracion transdermica de factores de crecimiento endotelial vascular
|
CN102643818B
(zh)
|
2004-09-28 |
2014-04-09 |
夸克制药公司 |
寡核糖核苷酸以及其用于治疗脱发、肾衰竭和其它疾病的方法
|
JP2006116086A
(ja)
*
|
2004-10-21 |
2006-05-11 |
Tokuyama Corp |
イオントフォレーシス装置用作用極構造体及びイオントフォレーシス装置
|
US20060095001A1
(en)
*
|
2004-10-29 |
2006-05-04 |
Transcutaneous Technologies Inc. |
Electrode and iontophoresis device
|
US20060135906A1
(en)
*
|
2004-11-16 |
2006-06-22 |
Akihiko Matsumura |
Iontophoretic device and method for administering immune response-enhancing agents and compositions
|
JP4728631B2
(ja)
*
|
2004-11-30 |
2011-07-20 |
Tti・エルビュー株式会社 |
イオントフォレーシス装置
|
US7590444B2
(en)
*
|
2004-12-09 |
2009-09-15 |
Tti Ellebeau, Inc. |
Iontophoresis device
|
KR20070090907A
(ko)
*
|
2004-12-09 |
2007-09-06 |
트랜스큐 테크놀로지스 가부시키가이샤 |
이온토포레시스 장치
|
JP4731931B2
(ja)
*
|
2005-02-03 |
2011-07-27 |
Tti・エルビュー株式会社 |
イオントフォレーシス装置
|
KR20070101303A
(ko)
*
|
2005-02-03 |
2007-10-16 |
트랜스큐 테크놀로지스 가부시키가이샤 |
이온토포레시스 장치
|
CA2597931A1
(en)
*
|
2005-02-16 |
2006-08-24 |
Alza Corporation |
Apparatus and method for transdermal delivery of erythropoetin-based agents
|
WO2006089285A1
(en)
*
|
2005-02-16 |
2006-08-24 |
Alza Corporation |
Microprojection arrays with improved biocompatibility
|
TW200640526A
(en)
*
|
2005-02-24 |
2006-12-01 |
Alza Corp |
Transdermal electrotransport drug delivery systems with reduced abuse potential
|
JP4793806B2
(ja)
|
2005-03-22 |
2011-10-12 |
Tti・エルビュー株式会社 |
イオントフォレーシス装置
|
JP2006296511A
(ja)
*
|
2005-04-15 |
2006-11-02 |
Transcutaneous Technologies Inc |
外用剤、外用剤の塗布方法、イオントフォレーシス装置及び経皮パッチ
|
WO2006130869A1
(en)
*
|
2005-06-02 |
2006-12-07 |
Alza Corporation |
Method for terminal sterilization of transdermal delivery devices
|
AU2006252377A1
(en)
*
|
2005-06-02 |
2006-12-07 |
Alza Corporation |
Method for terminal sterilization of transdermal delivery devices
|
JP2006334164A
(ja)
*
|
2005-06-02 |
2006-12-14 |
Transcutaneous Technologies Inc |
イオントフォレーシス装置及びその制御方法
|
JP2006346368A
(ja)
*
|
2005-06-20 |
2006-12-28 |
Transcutaneous Technologies Inc |
イオントフォレーシス装置及びその製造方法
|
JP2007000342A
(ja)
*
|
2005-06-23 |
2007-01-11 |
Transcutaneous Technologies Inc |
複数薬剤の投与量および投与時期を制御するイオントフォレーシス装置
|
JPWO2007010900A1
(ja)
*
|
2005-07-15 |
2009-01-29 |
Tti・エルビュー株式会社 |
貼付位置表示機能付き経皮吸収用パッチ及びイオントフォレーシス装置
|
KR100719095B1
(ko)
*
|
2005-07-29 |
2007-05-17 |
성균관대학교산학협력단 |
연료 확산속도 제어물질층을 포함하여 메탄올 크로스오버현상을 억제시킨 직접 메탄올 연료전지
|
US8295922B2
(en)
|
2005-08-08 |
2012-10-23 |
Tti Ellebeau, Inc. |
Iontophoresis device
|
US8386030B2
(en)
*
|
2005-08-08 |
2013-02-26 |
Tti Ellebeau, Inc. |
Iontophoresis device
|
US20070088332A1
(en)
*
|
2005-08-22 |
2007-04-19 |
Transcutaneous Technologies Inc. |
Iontophoresis device
|
JPWO2007023907A1
(ja)
*
|
2005-08-24 |
2009-02-26 |
Tti・エルビュー株式会社 |
冷凍型イオントフォレーシス用電極構造体
|
JPWO2007026672A1
(ja)
*
|
2005-08-29 |
2009-03-05 |
Tti・エルビュー株式会社 |
イオントフォレーシス用汎用性電解液組成物
|
WO2007029611A1
(ja)
*
|
2005-09-06 |
2007-03-15 |
Tti Ellebeau, Inc. |
イオントフォレーシス装置
|
US20070112294A1
(en)
*
|
2005-09-14 |
2007-05-17 |
Transcutaneous Technologies Inc. |
Iontophoresis device
|
RU2008114490A
(ru)
|
2005-09-15 |
2009-10-20 |
ТиТиАй ЭЛЛЕБО, ИНК. (JP) |
Устройство ионтофореза стержневого типа
|
KR20080056200A
(ko)
*
|
2005-09-16 |
2008-06-20 |
티티아이 엘뷰 가부시키가이샤 |
카테터형 이온토포레시스 장치
|
WO2007037324A1
(ja)
*
|
2005-09-28 |
2007-04-05 |
Transcu Ltd. |
乾燥型イオントフォレーシス用電極構造体
|
WO2007038028A1
(en)
*
|
2005-09-28 |
2007-04-05 |
Tti Ellebeau, Inc. |
Iontophoresis apparatus and method to deliver active agents to biological interfaces
|
EP1941929A1
(en)
*
|
2005-09-30 |
2008-07-09 |
Tti Ellebeau, Inc. |
Electrode structure for iontophoresis comprising shape memory separator, and iontophoresis apparatus comprising the same
|
KR20080066712A
(ko)
*
|
2005-09-30 |
2008-07-16 |
티티아이 엘뷰 가부시키가이샤 |
관능화된 미세바늘 경피 약물 전달 시스템, 장치 및 방법
|
US20070083185A1
(en)
*
|
2005-09-30 |
2007-04-12 |
Darrick Carter |
Iontophoretic device and method of delivery of active agents to biological interface
|
JPWO2007037476A1
(ja)
*
|
2005-09-30 |
2009-04-16 |
Tti・エルビュー株式会社 |
睡眠導入剤と興奮剤の投与量および投与時期を制御するイオントフォレーシス装置
|
US20070083186A1
(en)
*
|
2005-09-30 |
2007-04-12 |
Darrick Carter |
Transdermal drug delivery systems, devices, and methods employing novel pharmaceutical vehicles
|
CA2664589A1
(en)
*
|
2005-09-30 |
2007-04-12 |
Tti Ellebeau, Inc. |
Iontophoretic device and method of delivery of active agents to biological interface
|
JP2009509677A
(ja)
*
|
2005-09-30 |
2009-03-12 |
Tti・エルビュー株式会社 |
小胞封入活性物質のイオントフォレーシス送達
|
US20070074590A1
(en)
*
|
2005-09-30 |
2007-04-05 |
Transcutaneous Technologies Inc. |
Method and system to detect malfunctions in an iontophoresis device that delivers active agents to biological interfaces
|
US20070135754A1
(en)
*
|
2005-09-30 |
2007-06-14 |
Hidero Akiyama |
Electrode assembly for iontophoresis for administering active agent enclosed in nanoparticle and iontophoresis device using the same
|
US20070093787A1
(en)
*
|
2005-09-30 |
2007-04-26 |
Transcutaneous Technologies Inc. |
Iontophoresis device to deliver multiple active agents to biological interfaces
|
US20070197955A1
(en)
*
|
2005-10-12 |
2007-08-23 |
Transcutaneous Technologies Inc. |
Mucous membrane adhesion-type iontophoresis device
|
US20080033338A1
(en)
*
|
2005-12-28 |
2008-02-07 |
Smith Gregory A |
Electroosmotic pump apparatus and method to deliver active agents to biological interfaces
|
WO2007079189A2
(en)
*
|
2005-12-30 |
2007-07-12 |
Tti Ellebeau, Inc. |
System and method for remote based control of an iontophoresis device
|
JP2009522011A
(ja)
*
|
2005-12-30 |
2009-06-11 |
Tti・エルビュー株式会社 |
活性物質を生体界面に送達するイオントフォレーシスシステム、装置及び方法
|
EP1981910B1
(en)
|
2006-01-13 |
2013-06-26 |
A Chan Holding B.V. |
Method for identifying inhibitor of the glypican-sclerostin interaction
|
UY30097A1
(es)
|
2006-01-20 |
2007-08-31 |
Atugen Ag |
Usos terapeuticos de inhibidores de rtp801
|
US20080039775A1
(en)
*
|
2006-03-15 |
2008-02-14 |
Alza Corporation |
Apparatus and Method for Transdermal Delivery of Parathyroid Hormone Agents to Prevent or Treat Osteopenia
|
WO2007123707A1
(en)
*
|
2006-03-30 |
2007-11-01 |
Tti Ellebeau, Inc. |
Controlled release membrane and methods of use
|
US20080004671A1
(en)
*
|
2006-06-28 |
2008-01-03 |
Alza Corporation |
Vagus nerve stimulation via orally delivered apparatus
|
US20080009782A1
(en)
*
|
2006-06-28 |
2008-01-10 |
Alza Corporation |
Methods and Devices for Transdermal Electrotransport Delivery of Lofentanil and Carfentanil
|
JP2010502292A
(ja)
|
2006-09-05 |
2010-01-28 |
Tti・エルビュー株式会社 |
イオントフォレーシス薬物送達装置を評価するための非破壊システム、装置及び方法
|
EP2061553A2
(en)
|
2006-09-05 |
2009-05-27 |
Tti Ellebeau, Inc. |
Impedance systems, devices and methods for evaluating iontophoretic properties of compounds
|
WO2008030497A2
(en)
*
|
2006-09-05 |
2008-03-13 |
Tti Ellebeau, Inc. |
Transdermal drug delivery systems, devices, and methods using inductive power supplies
|
US20080260678A1
(en)
*
|
2006-10-10 |
2008-10-23 |
University Of Colorado |
Molecular band-aid
|
JP2010507387A
(ja)
|
2006-10-25 |
2010-03-11 |
クアーク・ファーマスーティカルス、インコーポレイテッド |
新規のsiRNAおよびその使用方法
|
KR20090106492A
(ko)
|
2006-12-01 |
2009-10-09 |
티티아이 엘뷰 가부시키가이샤 |
경피성 전달 장치와 같은 장치에 전력을 제공하거나 제어하기 위한 시스템, 장치, 및 방법
|
JPWO2008087884A1
(ja)
|
2007-01-16 |
2010-05-06 |
Tti・エルビュー株式会社 |
薬物投与量の予測方法及びそのプログラム
|
US20080188791A1
(en)
*
|
2007-02-02 |
2008-08-07 |
Difiore Attilio E |
Active iontophoresis delivery system
|
MX2009012273A
(es)
*
|
2007-05-18 |
2010-04-09 |
Tti Ellebeau Inc |
Dispositivos de suministro transd?rmico que aseguran la liberaci?n mejorada de un principio activo a trav?s de una interfaz biol?gica.
|
US8197844B2
(en)
*
|
2007-06-08 |
2012-06-12 |
Activatek, Inc. |
Active electrode for transdermal medicament administration
|
US8729121B2
(en)
|
2007-06-25 |
2014-05-20 |
Adhezion Biomedical, Llc |
Curing accelerator and method of making
|
ES2454974T3
(es)
*
|
2007-06-27 |
2014-04-14 |
The General Hospital Corporation |
Aparato para la inhibición óptica de la terapia fotodinámica
|
DK2170403T3
(da)
|
2007-06-27 |
2014-06-16 |
Quark Pharmaceuticals Inc |
Sammensætninger og fremgangsmåder til hæmning af ekspressionen af proapoptotiske gener
|
CN103898110A
(zh)
|
2007-10-03 |
2014-07-02 |
夸克制药公司 |
新siRNA结构
|
US8613952B2
(en)
|
2007-11-14 |
2013-12-24 |
Adhezion Biomedical, Llc |
Cyanoacrylate tissue adhesives
|
US8862223B2
(en)
|
2008-01-18 |
2014-10-14 |
Activatek, Inc. |
Active transdermal medicament patch and circuit board for same
|
EP2106791A1
(en)
|
2008-03-31 |
2009-10-07 |
Biotempt B.V. |
Glutamine or glutamine-containing dipeptide in a specific dosage for the treatment of inflammation
|
WO2009148613A1
(en)
*
|
2008-06-04 |
2009-12-10 |
Coda Therapeutics, Inc. |
Treatment of pain with gap junction modulation compounds
|
US8198344B2
(en)
|
2008-06-20 |
2012-06-12 |
Adhezion Biomedical, Llc |
Method of preparing adhesive compositions for medical use: single additive as both the thickening agent and the accelerator
|
US8293838B2
(en)
|
2008-06-20 |
2012-10-23 |
Adhezion Biomedical, Llc |
Stable and sterile tissue adhesive composition with a controlled high viscosity
|
US20110117047A1
(en)
|
2008-06-23 |
2011-05-19 |
Adhezion Biomedical, Llc |
Cyanoacrylate tissue adhesives with desirable permeability and tensile strength
|
AU2009291764A1
(en)
*
|
2008-09-10 |
2010-03-18 |
Transcu Ltd. |
Apparatus and method to dispense HPC-based viscous liquids into porous substrates, e.g., continuous web-based process
|
US8609128B2
(en)
|
2008-10-31 |
2013-12-17 |
Adhezion Biomedical, Llc |
Cyanoacrylate-based liquid microbial sealant drape
|
US8652510B2
(en)
|
2008-10-31 |
2014-02-18 |
Adhezion Biomedical, Llc |
Sterilized liquid compositions of cyanoacrylate monomer mixtures
|
US9254133B2
(en)
|
2008-10-31 |
2016-02-09 |
Adhezion Biomedical, Llc |
Sterilized liquid compositions of cyanoacrylate monomer mixtures
|
US20110288155A1
(en)
|
2008-12-18 |
2011-11-24 |
Elena Feinstein |
Sirna compounds and methods of use thereof
|
US8961492B2
(en)
|
2009-02-12 |
2015-02-24 |
Incube Labs, Llc |
System and method for controlling the iontophoretic delivery of therapeutic agents based on user inhalation
|
US8190252B2
(en)
|
2009-02-12 |
2012-05-29 |
Incube Labs, Llc |
Iontophoretic system for transdermal delivery of active agents for therapeutic and medicinal purposes
|
US9008765B2
(en)
|
2009-02-12 |
2015-04-14 |
Incube Labs, Llc |
System and method for biphasic transdermal iontophoretic delivery of therapeutic agents for the control of addictive cravings
|
ES2655714T3
(es)
|
2009-02-26 |
2018-02-21 |
The University Of North Carolina At Chapel Hill |
Sistema intervencionista de administración de fármacos
|
CA2756574C
(en)
|
2009-03-26 |
2020-01-28 |
Henry Ford Health System |
Thymosin .beta.4 for treating neural injury by myelinating damaged neurons
|
JP2012525943A
(ja)
*
|
2009-05-08 |
2012-10-25 |
アイシス バイオポリマー,インク. |
改良された対電極を備えるイオントフォレシス装置
|
US20110092881A1
(en)
*
|
2009-05-08 |
2011-04-21 |
Isis Biopolymer Inc. |
Iontophoretic device with contact sensor
|
DK3276004T3
(da)
|
2009-06-08 |
2020-04-06 |
Quark Pharmaceuticals Inc |
Fremgangsmåder til behandling af kronisk nyresygdom
|
US20100312168A1
(en)
*
|
2009-06-09 |
2010-12-09 |
Yoshimasa Yoshida |
Long life high capacity electrode, device, and method of manufacture
|
US8903485B2
(en)
|
2009-08-06 |
2014-12-02 |
Incube Labs, Llc |
Patch and patch assembly for iontophoretic transdermal delivery of active agents for therapeutic and medicinal purposes
|
NZ599237A
(en)
|
2009-11-26 |
2014-03-28 |
Quark Pharmaceuticals Inc |
Sirna compounds comprising terminal substitutions
|
US8685038B2
(en)
|
2009-12-07 |
2014-04-01 |
Incube Labs, Llc |
Iontophoretic apparatus and method for marking of the skin
|
KR101692063B1
(ko)
|
2009-12-09 |
2017-01-03 |
닛토덴코 가부시키가이샤 |
hsp47 발현의 조절
|
WO2011072091A1
(en)
|
2009-12-09 |
2011-06-16 |
Quark Pharmaceuticals, Inc. |
Methods and compositions for treating diseases, disorders or injury of the cns
|
JP5463136B2
(ja)
*
|
2009-12-22 |
2014-04-09 |
帝國製薬株式会社 |
イオントフォレーシス療法に用いる電極装置
|
WO2011084193A1
(en)
|
2010-01-07 |
2011-07-14 |
Quark Pharmaceuticals, Inc. |
Oligonucleotide compounds comprising non-nucleotide overhangs
|
US8986279B2
(en)
|
2010-02-10 |
2015-03-24 |
Incube Labs, Llc |
Methods and architecture for power optimization of iontophoretic transdermal drug delivery
|
WO2011103569A1
(en)
|
2010-02-22 |
2011-08-25 |
Health Enhancement Products, Inc. |
Agents and mechanisms for treating hypercholesterolemia
|
CN107115326B
(zh)
|
2010-04-13 |
2021-01-22 |
雷尔玛达治疗股份有限公司 |
1-甲基-n-(2,6-二甲苯基)-2-哌啶甲酰胺的皮肤用药物组合物及其使用方法
|
US9309019B2
(en)
|
2010-05-21 |
2016-04-12 |
Adhezion Biomedical, Llc |
Low dose gamma sterilization of liquid adhesives
|
CA2801928C
(en)
|
2010-06-24 |
2018-04-10 |
Quark Pharmaceuticals, Inc. |
Double stranded rna compounds to rhoa and use thereof
|
US20140134231A1
(en)
|
2010-10-11 |
2014-05-15 |
Sanford-Burnham Medical Research Institute |
Mir-211 expression and related pathways in human melanoma
|
CN103298939A
(zh)
|
2010-12-06 |
2013-09-11 |
夸克医药公司 |
包含位置修饰的双链寡核苷酸化合物
|
US9796979B2
(en)
|
2011-03-03 |
2017-10-24 |
Quark Pharmaceuticals Inc. |
Oligonucleotide modulators of the toll-like receptor pathway
|
KR101937498B1
(ko)
|
2011-03-03 |
2019-04-10 |
쿠아크 파마수티칼스 인코퍼레이티드 |
폐 질환 및 손상을 치료하기 위한 조성물 및 방법
|
SG193280A1
(en)
|
2011-03-03 |
2013-10-30 |
Quark Pharmaceuticals Inc |
Oligonucleotide modulators of the toll-like receptor pathway
|
JP6133843B2
(ja)
|
2011-03-24 |
2017-05-31 |
インキューブ ラブズ,リミテッド ライアビリティー カンパニーInCube Labs,LLC |
治療剤の二相性経皮イオン泳動送達用のシステム及び方法
|
US8781571B2
(en)
|
2011-03-31 |
2014-07-15 |
Incline Therapeutics, Inc. |
Switch validation circuit and method
|
US9731121B2
(en)
|
2011-03-31 |
2017-08-15 |
Incline Therapeutics, Inc. |
Switch validation circuit and method
|
US8428708B1
(en)
|
2012-05-21 |
2013-04-23 |
Incline Therapeutics, Inc. |
Self-test for analgesic product
|
US8428709B1
(en)
|
2012-06-11 |
2013-04-23 |
Incline Therapeutics, Inc. |
Current control for electrotransport drug delivery
|
WO2013003697A1
(en)
|
2011-06-30 |
2013-01-03 |
Trustees Of Boston University |
Method for controlling tumor growth, angiogenesis and metastasis using immunoglobulin containing and proline rich receptor-1 (igpr-1)
|
US20130090633A1
(en)
*
|
2011-10-07 |
2013-04-11 |
University Of Southern California |
Osmotic patch pump
|
EP2776565A1
(en)
|
2011-11-08 |
2014-09-17 |
Quark Pharmaceuticals, Inc. |
Methods and compositions for treating diseases, disorders or injury of the nervous system
|
CA2858336A1
(en)
|
2012-01-01 |
2013-07-04 |
Qbi Enterprises Ltd. |
Endo180-targeted particles for selective delivery of therapeutic and diagnostic agents
|
KR20140111673A
(ko)
|
2012-01-12 |
2014-09-19 |
쿠아크 파마수티칼스 인코퍼레이티드 |
청력 및 균형 장애를 치료하기 위한 조합요법
|
EP3269372B1
(en)
|
2012-01-19 |
2019-06-12 |
Hybrid Medical, LLC |
Topical therapeutic formulations
|
US9314571B1
(en)
*
|
2012-02-10 |
2016-04-19 |
Mphase Technologies, Inc. |
Drug delivery system
|
CA2868534A1
(en)
|
2012-03-27 |
2013-10-03 |
Coda Therapeutics, Inc. |
Compositions and treatments based on cadherin modulation
|
CN104768567B
(zh)
|
2012-05-18 |
2017-07-11 |
奥塔哥创业有限公司 |
用于伤口愈合的联合治疗和组合物
|
SG11201407322QA
(en)
|
2012-05-23 |
2014-12-30 |
Cellix Bio Private Ltd |
Compositions and methods for the treatment of multiple sclerosis
|
WO2013175357A2
(en)
|
2012-05-23 |
2013-11-28 |
Mahesh Kandula |
Compositions and methods for the treatment of inflammatory bowel disease
|
US20130315891A1
(en)
|
2012-05-25 |
2013-11-28 |
Matthew Charles |
Formulations of human tissue kallikrein-1 for parenteral delivery and related methods
|
HUE032613T2
(en)
|
2012-06-04 |
2017-10-30 |
Diamedica Therapeutics Inc |
Human tissue kallikrein 1 is glycosylated isoforms
|
EP2864360B1
(en)
|
2012-06-25 |
2017-09-06 |
The Brigham and Women's Hospital, Inc. |
Targeted therapeutics
|
EP2895608B1
(en)
|
2012-09-12 |
2018-12-05 |
Quark Pharmaceuticals, Inc. |
Double-stranded oligonucleotide molecules to p53 and methods of use thereof
|
ES2872349T3
(es)
|
2012-09-12 |
2021-11-02 |
Quark Pharmaceuticals Inc |
Moléculas de oligonucleótidos bicatenarios para DDIT4 y métodos de uso de las mismas
|
US9611473B2
(en)
|
2012-09-12 |
2017-04-04 |
Quark Pharmaceuticals, Inc. |
Double-stranded nucleic acid compounds
|
EP2934540B1
(en)
|
2012-12-24 |
2023-08-02 |
Neurogastrx, Inc. |
Methods for treating gi tract disorders
|
KR20160029731A
(ko)
|
2013-03-12 |
2016-03-15 |
더 제너럴 하스피탈 코포레이션 |
변형된 뮐러관 억제 물질(mis) 단백질 및 질환 치료를 위한 그 용도
|
US10232028B2
(en)
|
2013-06-13 |
2019-03-19 |
Zivo Bioscience, Inc. |
Compounds and methods for affecting cytokines
|
WO2015020960A1
(en)
|
2013-08-09 |
2015-02-12 |
Novartis Ag |
Novel lncrna polynucleotides
|
JP6118456B2
(ja)
*
|
2013-09-19 |
2017-04-19 |
コーニンクレッカ フィリップス エヌ ヴェKoninklijke Philips N.V. |
無線周波数電流を用いた皮膚のための処置装置
|
DK3079712T3
(da)
|
2013-12-11 |
2022-04-25 |
Massachusetts Gen Hospital |
Anvendelse af müllersk inhiberende substans- (mis) proteiner til kontraception og ovariereservebevarelse
|
US9421297B2
(en)
|
2014-04-02 |
2016-08-23 |
Adhezion Biomedical, Llc |
Sterilized compositions of cyanoacrylate monomers and naphthoquinone 2,3-oxides
|
US9844554B2
(en)
|
2014-06-24 |
2017-12-19 |
Neurogastrx, Inc. |
Prodrugs of metopimazine
|
EP3240779B1
(en)
|
2014-09-26 |
2020-10-28 |
Cellixbio Private Limited |
Compositions and methods for the treatment of epilepsy and neurological disorders
|
AU2014407862B2
(en)
|
2014-09-29 |
2020-03-26 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of multiple sclerosis
|
JP6564868B2
(ja)
|
2014-10-27 |
2019-08-21 |
セリックス バイオ プライヴェート リミテッドCellix Bio Private Limited |
多発性硬化症の治療のための、フマル酸モノメチルエステルとピペラジン又はエチレンジアミンとの3つの成分の塩
|
WO2016067297A1
(en)
|
2014-10-27 |
2016-05-06 |
Cellix Bio Private Limited |
Salts of valproic acid with piperazine, ethylenediamine, lysine and/or eicosapentaenoic ecid (epa) amine derivatives for the treatment of epilepsy
|
CA2969330A1
(en)
|
2014-12-01 |
2016-06-09 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of multiple sclerosis
|
SG11201706369PA
(en)
|
2015-02-09 |
2017-09-28 |
Cellix Bio Private Ltd |
Compositions and methods for the treatment of mucositis
|
EP3258948B1
(en)
|
2015-02-16 |
2023-12-06 |
Zivo Bioscience, Inc. |
Anti-inflammatory and immunomodulatory compositions comprising klebsormidium and uses thereof
|
FR3034017B1
(fr)
|
2015-03-24 |
2018-11-02 |
Feeligreen |
Matrice polymerique adhesive pour iontophorese et dispositif pour l'iontophorese comprenant ladite matrice
|
EP3416501A4
(en)
|
2016-02-16 |
2019-11-20 |
Zivo Bioscience, Inc. |
NUTRITIONAL SUPPORT OF ANIMALS BY ADMINISTRATION OF A SUPPLEMENT BASED ON ALGAE
|
EP3416618A1
(en)
|
2016-02-19 |
2018-12-26 |
ZP Opco, Inc. |
Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines
|
CA3031893A1
(en)
|
2016-08-11 |
2018-02-15 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of irritable bowel syndrome
|
WO2018065831A1
(en)
|
2016-10-04 |
2018-04-12 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of xerostomia
|
CA3044755A1
(en)
|
2016-11-28 |
2018-05-31 |
Cellix Bio Private Limited |
Compositions and methods for the treatment of fungal infections
|
EP3554494A4
(en)
|
2016-12-19 |
2021-02-17 |
Cellixbio Private Limited |
COMPOSITIONS AND METHODS FOR THE TREATMENT OF INFLAMMATION
|
EP3592377A4
(en)
|
2017-03-09 |
2021-02-17 |
Diamedica Inc. |
DOSAGE FORMS OF TISSUE KALLIKREIN 1
|
AU2017428907B2
(en)
|
2017-08-23 |
2021-12-16 |
Zosano Pharma Corporation |
Method of rapidly achieving therapeutic concentrations of zolmitriptan for treatment of migraines and cluster headaches
|
US11660264B2
(en)
|
2017-08-23 |
2023-05-30 |
Emergex USA Corporation |
Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines and cluster headaches
|
EP3697535B1
(en)
|
2017-10-18 |
2023-04-26 |
Nuclera Nucleics Ltd |
Digital microfluidic devices including dual substrates with thin-film transistors and capacitive sensing
|
SG11202004019SA
(en)
|
2017-11-17 |
2020-05-28 |
Cellix Bio Private Ltd |
Compositions and methods for the treatment of eye disorders
|
CA3081482A1
(en)
|
2017-11-17 |
2019-05-23 |
Cellix Bio Private Limited |
Compounds, compositions and methods for treatment of eye disorders and skin diseases
|
US11660265B2
(en)
|
2018-06-28 |
2023-05-30 |
Emergex USA Corporation |
Method of rapidly achieving therapeutic concentrations of triptans for treatment of migraines and cluster headaches
|
US11724024B2
(en)
*
|
2018-07-24 |
2023-08-15 |
University Of Maryland, College Park |
Inverted battery devices, and systems and methods for use thereof
|
US11353759B2
(en)
|
2018-09-17 |
2022-06-07 |
Nuclera Nucleics Ltd. |
Backplanes with hexagonal and triangular electrodes
|
CN112839700B
(zh)
*
|
2018-10-15 |
2023-05-02 |
伊英克公司 |
数字微流控输送装置
|
JP7465271B2
(ja)
*
|
2019-01-09 |
2024-04-10 |
トゥウェンティ トゥウェンティ セラピューティクス エルエルシー |
治療剤放出のための眼球装着装置
|
US10836757B1
(en)
|
2020-04-02 |
2020-11-17 |
Neurogastrx, Inc. |
Polymorphic forms of metopimazine
|
EP3922720A1
(en)
|
2020-06-09 |
2021-12-15 |
Universidad de Murcia |
Therapy to prevent adverse cardiac remodeling following an acute myocardial infarction
|
JP2024501948A
(ja)
*
|
2020-12-30 |
2024-01-17 |
ジョージア テック リサーチ コーポレイション |
医療診断のための汗の誘導のための方法及びデバイス
|
US20220265582A1
(en)
|
2021-02-24 |
2022-08-25 |
Universitätsspital Basel |
Effects of mescaline and of mescaline analogs (scalines) to assist psychotherapy
|
US11801256B2
(en)
|
2021-06-08 |
2023-10-31 |
Universitätsspital Basel |
Antidepressant-psilocybin co-treatment to assist psychotherapy
|